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Abstract
Background: Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) and Cerebral Dopamine Neurotrophic
Factor (CDNF) form an evolutionarily conserved family of neurotrophic factors. Orthologues for MANF/CDNF are the only
neurotrophic factors as yet identified in invertebrates with conserved amino acid sequence. Previous studies indicate that
mammalian MANF and CDNF support and protect brain dopaminergic system in non-cell-autonomous manner.
However, MANF has also been shown to function intracellularly in the endoplasmic reticulum. To date, the knowledge on
the interacting partners of MANF/CDNF and signaling pathways they activate is rudimentary. Here, we have employed
the Drosophila genetics to screen for potential interaction partners of Drosophila Manf (DmManf) in vivo.
Results: We first show that DmManf plays a role in the development of Drosophila wing. We exploited this function by
using Drosophila UAS-RNAi lines and discovered novel genetic interactions of DmManf with genes known to function in
the mitochondria. We also found evidence of an interaction between DmManf and the Drosophila homologue encoding
Ku70, the closest structural homologue of SAP domain of mammalian MANF.
Conclusions: In addition to the previously known functions of MANF/CDNF protein family, DmManf also interacts with
mitochondria-related genes. Our data supports the functional importance of these evolutionarily significant proteins and
provides new insights for the future studies.
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Background
An evolutionarily conserved protein family, MANF/
CDNF family, is the most recently discovered family of
neurotrophic factors (NTFs) [1–4]. Typically of NTFs,
MANF and CDNF are small secreted molecules that
support the survival of neurons [1, 2]. Mammalian
MANF and CDNF support the brain dopaminergic
system in rodent models of Parkinson’s disease (PD) in
vivo [2, 5, 6]. MANF has been shown to protect neurons
and cardiomyocytes against ischemic injury in extracel-
lular manner [7, 8]. Additionally, MANF is required for
the proliferation and survival of the pancreatic β-cells [9].
Orthologues for MANF/CDNF are the only neuro-
trophic factors as yet identified in invertebrates with
conserved amino acid sequence [1, 3]. The invertebrate
homologues show higher similarity to mammalian
MANF than CDNF [2, 3]. However, both human MANF
and CDNF are functional orthologues of Drosophila
Manf (DmManf ) [3, 10]. In Drosophila, glial-derived
DmManf is necessary for maintaining the neurites of
embryonic and larval dopaminergic neurons that do not
express DmManf. This demonstrates that the extracel-
lular trophic function for dopaminergic system is
conserved [3].
The knowledge on the molecular interactions of
MANF/CDNF family proteins remains limited. Also the
receptor for MANF/CDNF proteins is not known. Intra-
cellularly, mammalian MANF has been shown to bind
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GRP78/BiP (Glucose-regulated protein 78/Binding im-
munoglobulin protein), the major ER chaperone, in
Ca2+-dependent manner [8]. There is also experimental
evidence suggesting that MANF interacts with KDEL-
Rs, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum
protein retention receptors [11]. Furthermore, a recent
study suggests that MANF interacts with a member of
ER-associated reticulon protein family [12]. Our previ-
ous study shows a genetic interaction between DmManf
and Drosophila homologues of GRP78, PERK (PRKR-like
endoplasmic reticulum kinase, one of the ER stress
sensor proteins) and Xbp1 (X-box Binding Protein-1, a
transcription factor mainly mediating ER stress response
activated gene expression) [13]. Additionally, our earlier
microarray analysis suggests that DmManf has a role in
Drosophila ER stress response [14]. MANF is localized to
ER [14–17] and the retention is mediated through the
non-classical but evolutionarily conserved ER retention
signal sequence, RTDL in human and RSEL in Drosophila
[8, 10, 17]. Furthermore, the expression of Manf mRNA is
induced in response to ER stress [13, 15, 17–20]. In
addition to GRP78, co-immunoprecipitation studies
have revealed that MANF (also known as Armet) in-
teracts with a mutant form of an extracellular matrix
protein matrilin 3 [21].
Both mammalian and Drosophila MANF have been
shown to hold intracellular cytoprotective function
against Bax (BCL-2 associated X) -dependent cell death
in vitro [10, 22]. The C-terminal domain of MANF
shows high structural homology to SAP (SAF-A/B, Aci-
nus and PIAS) domain of Ku70 (Ku autoantigen p70
subunit), an inhibitor of Bax-mediated apoptosis [23],
and it is alone capable of protecting neurons from
induced apoptosis in vitro [10, 22].
MANF and CDNF have been suggested to be involved
in inflammatory responses [24–28]. The main mediator
of proinflammatory response, NF-κB (nuclear factor
kappa-light-chain-enhancer of activated B cells), is also
regulated by unfolded protein response, a cellular
process activated by ER stress (reviewed e.g. in [29]). In
a recent study MANF was found to bind the p65 subunit
of NF-κB via the C-terminal SAP-domain in vitro [28].
Upon inflammation, MANF localized to nucleus and
was suggested to suppress the expression of NF-κB
targets by binding to DNA binding domain of p65 as
well as to adjacent enhancer regions of target genes [28].
Interestingly, recent study demonstrated that MANF has
a conserved immune modulatory function in both
Drosophila and mouse promoting tissue repair and
regeneration in retina [30].
In this work we used RNA interference (RNAi) ap-
proach in UAS/GAL4 in vivo system to study interacting
partners of DmManf in Drosophila model. In the binary
UAS/GAL4 system, GAL4 lines with various expression
patterns are used for tissue-specific expression of UAS
(upstream activation sequence) -transgenes [31]. RNAi
where double stranded RNA (dsRNA) induces the
degradation of targeted mRNA [32] is commonly used
for gene silencing. Transgenic genome-wide Drosophila
RNAi libraries have been established [33] (http://
www.shigen.nig.ac.jp/fly/nigfly/) by introducing dsRNAs
under UAS promotor. Crossing these flies with different
GAL4 driver lines enables tissue-specific target gene
inactivation. Expression of other UAS constructs or
markers (e.g. GFP) can be simultaneously activated in
the same GAL4 expression pattern. In this study, we
used UAS-DmManf-RNAi construct for targeted
knockdown of DmManf and performed a partial, un-
biased screen of RNAi libraries in vivo to discover novel
interacting partners for DmManf. Here we demonstrate
genetic interactions between DmManf and genes with
mitochondrial function.
Results
Silencing of DmManf by UAS-DmManf-RNAi is effective
and specific in vivo
Homozygous DmManf mutants die at early developmental
stage [3]. To study the role of DmManf during later stages
of development we used the UAS/GAL4 system for tissue-
specific knockdown of DmManf [31, 33]. Three UAS-
DmManf-RNAi fly stocks were obtained from Vienna Dros-
ophila RNAi Center (VDRC) (A in Additional file 1). All
transformant lines showed similar phenotypes with
different GAL4 drivers (B in Additional file 1), and the
transformant line 12835 with construct ID 4793 was used
in further experiments.
The ubiquitous knockdown of DmManf with tub-
GAL4 and da-GAL4 drivers in wild type background
showed lethal phenotype at larval to pupal stage (Fig.
1a–b and data not shown). The knockdown efficiency of
DmManf expression was verified at both mRNA and
protein level by quantitative RT-PCR (qPCR) and
Western blot analyses, respectively (Fig. 1c–d). When
the ubiquitous knockdown of DmManf was performed
in heterozygous DmManfΔ96 mutant background with
already decreased DmManf protein level, the lethality
was observed at early larval stage (Fig. 1a) resembling
the phenotype of homozygous DmManfΔ96 mutants [3].
According to information provided by VDRC, there
are no predicted off-targets for DmManf-RNAi
construct ID 4793. To verify the specificity of DmManf-
RNAi, DmManf was simultaneously overexpressed (by
UAS-DmManfL3) and knocked down (by UAS-
DmManf-RNAi) with ubiquitous tub-GAL4 driver. The
overexpression of DmManf rescued the pupal lethality
phenotype of ubiquitous DmManf knockdown flies into
adulthood (Fig. 1a–b). We also used overexpression of
the UAS constructs encoding transcripts for DmManf
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human (Hs) orthologues, HsMANF and HsCDNF, which
share less homology with the DmManf-RNAi construct (C
in Additional file 1) than DmManf. Both HsMANF and
HsCDNF rescued the pupal lethality observed in DmManf
ubiquitous knockdown flies (Fig. 1a–b). When two UAS
constructs are used in the same fly, GAL4 protein supply
is shared by the two promotor regions and might lead to
decreased expression of UAS targets. In the case of
UAS-RNAi lines, this dose effect could compromise the
knockdown efficiency. To confirm that the rescue of
DmManf knockdown phenotype was not due to inefficient
knockdown of DmManf, we used UAS-DmManf-RNAi;
UAS-mCD8-GFP line as a dose control for UAS/GAL4
binary expression system. Ubiquitous knockdown of
DmManf by UAS-DmManf-RNAi; UAS-mCD8-GFP with
tub-GAL4 showed similar proportion of expected pupae
to UAS-DmManf-RNAi alone (Fig. 1a–b).
Wing-specific knockdown of DmManf drastically alters
wing morphology and increases cell proliferation
DmManf is ubiquitously expressed in 3rd instar larval
wing disc [10]. To verify the efficiency of tissue-specific
silencing of DmManf, we used salm-GAL4 and en-GAL4
to knock down DmManf and simultaneously express
UAS-mCD8-GFP to visualize the GAL4 expression
pattern in the larval wing disc. The loss of DmManf
immunoreactivity was detected exactly according to
salm-GAL4 and en-GAL4 expression pattern in the wing
disc (Fig. 1e) further demonstrating that the knockdown
of DmManf was efficient at protein level. Interestingly,
in DmManf knockdown wing discs we detected mild but
clear increase of DmManf immunoreactivity in regions
next to the GAL4 expressing area (Fig. 1e). This
might indicate a compensatory regulation of DmManf
expression in response to the partial loss of DmManf
in the wing disc.
Interestingly, we observed two different wing pheno-
types when various drivers with GAL4 expression in the
wing were used to knock down DmManf in wild type
background. The knockdown with MS1096-GAL4,
A9-GAL4 and Ser-GAL4 drivers showed a three-
dimensional “bent-up” wing phenotype (b3 in Fig. 2a
and data not shown) while knockdown with 69B-GAL4
revealed blistered wing phenotype (Fig. 2b). The wing
phenotype was observed with full penetrance in males of
DmManf knockdown with MS1096-GAL4 (Table 1). To
verify further the specificity of DmManf knockdown, we
repeated the experiments in heterozygous DmManfΔ96
mutant background. With 69B-GAL4, the knockdown of
DmManf in heterozygous DmManfΔ96 mutant
background resulted in lethality. When MS1096-GAL4
driver was used to knock down DmManf in heterozygous
DmManfΔ96 mutant background, the wing phenotype was
stronger as compared to DmManf knockdown in wild
type background, especially in males in which the wing
blade was totally lost (b2 and b4 in Fig. 2a). In
comparison to females, the more severe knockdown
wing phenotype observed in males was likely due to
the dosage compensation of X-chromosomal GAL4
insertion in MS1096-GAL4 driver line.
Simultaneous expression of UAS-DmManfL3 and
UAS-DmManf-RNAi with MS1096-GAL4 returned the
wings back to wild type (c1-c2 in Fig. 2a) indicating that
overexpression of DmManf could rescue the wing
phenotype. Co-expression of UAS-HsMANF or UAS-
HsCDNF together with UAS-DmManf-RNAi by
MS1096-GAL4 also rescued the wing phenotype (d1-d4
and e1-e4 in Fig. 2a). This further demonstrated that the
knockdown of DmManf by UAS-DmManf-RNAi
construct was specific to the DmManf mRNA only and
suggests that DmManf plays an important role during
wing development.
To investigate whether DmManf is involved in regula-
tion of cell proliferation in vivo, we used the wing-speci-
fic knockdown of DmManf with MS1096-GAL4. Wing
discs of third instar male larvae were stained for a mi-
totic marker phosphorylated Histone-3 (pHis3) [34]. We
found that the number of pHis3 positive cells within
GFP-expressing wing area was significantly increased
when DmManf was knocked down in heterozygous
DmManfΔ96 mutant background in comparison to het-
erozygous DmManfΔ96 mutant alone (Fig. 3a–b). In
addition, we used UAS-S/G2/M-Green transgenic flies
based on the Fucci (fluorescent, ubiquitination-based
(See figure on previous page.)
Fig. 1 Knockdown of DmManf by UAS-DmManf-RNAi is effective and specific. a-b Quantification of pupae (a) and adults (b) of ubiquitous
knockdown of DmManf with tub-GAL4 driver. Ubiquitous knockdown of DmManf was lethal at larval stage with few escapers to pupal stage. UAS-mCD8-
GFP was used as a dose control for UAS/GAL4 binary expression system, tub-GAL4/+ as a wild type control. Amount of pupae and adults analysed are
presented in Additional file 8. Proportion of Tb+ pupae was normalized to experimentally determined proportion of Tb+ pupae (see Additional file 8, wild
type and wild type/SM6-TM6). c-d Quantitative RT-PCR (c) and Western blot (d) analyses revealed that ubiquitous knockdown of DmManf resulted in
robustly reduced DmManf mRNA and protein levels in larvae collected 50–54 h after egg laying. Homozygous DmManfΔ96 mutant showed diminished
level of maternally contributed DmManf mRNA and protein. tub-GAL4 > UAS-lacZ flies were used as a wild type control. DmManf mRNA levels were
normalized to wild type. Alpha-tubulin was used as a loading control for Western blot analysis. e Knockdown of DmManf with en-GAL4 and salm-GAL4
drivers showed a loss of DmManf immunoreactivity (magenta) in GAL4-expressing pattern. UAS-mCD8-GFP was used to detect GAL4 expression (green).
Single laser confocal sections. Scale bar 50 μm
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cell cycle indicator) model [35, 36]. act-His2AvRFP
transgene was used to visualize nuclei of all cells. We
fixed 3rd instar wing discs of male larvae and detected
increased proportion of S/G2/M cells in DmManf
knockdown with MS1096-GAL4 driver in comparison to
wild type (Fig. 3c–d). This further indicates that the loss
of DmManf affects cell cycle events.
Screening of DmManf interaction partners
The observed wing phenotype allowed us to perform a
straightforward genetic screen to identify novel genetic
interactions of DmManf. Overall scheme of our four-
staged RNAi screen is presented in Additional file 2. We
screened approximately 2800 RNAi lines (representing
about 20% of fly genome) from VDRC and National In-
stitute of Genetics (NIG, Japan) collections. The RNAi
lines were selected randomly to perform unbiased
screening for the interacting partners. The primary
screen was conducted with MS1096-GAL4 driver (E.
Vridolin and O. Shimmi, unpublished data) and RNAi
lines with similar wing phenotype to DmManf-RNAi
were selected for secondary screening. MS1096-GAL4 is
expressed in the pouch area of the wing disc (B in
Additional File 2, [37–39]), but we also detected a weak
Fig. 2 Loss of DmManf alters wing morphology. a Knockdown of DmManf with MS1096-GAL4 caused a “bent-up” phenotype in which the edges
of wings were curled upwards (b3). DmManf knockdown in heterozygous DmManfΔ96 mutant background showed more severe wing phenotype,
even total loss of the wing blade in adult males (b2 and b4). Wing phenotype was rescued by overexpression of DmManf (c1-c2), HsMANF
(d1-d4) and HsCDNF (e1-e4). MS1096-GAL4 flies were used as a wild type control (a1-a4). Scale bar 1 mm. b Knockdown of DmManf with
semi-ubiquitous driver 69B-GAL4 showed a blistered wing phenotype in adult females. Males showed lethal phenotype in wild type background,
females in heterozygous DmManfΔ96 mutant background. Scale bar 100 μm
Lindström et al. BMC Genetics  (2017) 18:52 Page 5 of 19
expression pattern in central nervous system (CNS) (C
in Additional File 2). For more efficient screening, we
focused on the wing phenotypes only. The secondary
screen was performed for approximately 400 RNAi lines
with two GAL4 drivers, MS1096-GAL4 and semi-ubi-
quitous 69B-GAL4, in both wild type and heterozygous
DmManfΔ96 mutant backgrounds to observe whether
the phenotype caused by silencing of a particular gene
would be altered by decreased DmManf expression level
[3]. 69B-GAL4 lacks expression in the fat body, gastric
caeca and muscles, and its expression patterns in the
CNS and cuticle are limited [10, 14]. In addition to its
semi-ubiquitous expression pattern, we chose 69B-GAL4
driver because DmManfΔ96 mutant lethality is fully
rescued by ectopic expression of UAS-DmManf with
69B-GAL4 [3]. About 80 RNAi lines showed altered
phenotype between wild type and heterozygous
DmManfΔ96Δ96 mutant background and were selected
for tertiary screening. In tertiary screening, we used
overexpression of DmManf together with knockdown of
candidate genes with 69B-GAL4 and MS1096-GAL4
drivers to study whether the increased level of DmManf
would affect the phenotypes caused by silencing of the
candidate genes. The overexpression of DmManf with
69B-GAL4 or MS1096-GAL4 alone showed no detect-
able phenotype in adults (D in Additional file 2). Based on
secondary and tertiary screening, we selected 21 genes as
candidate interacting partners of DmManf (Fig. 4). Exam-
ples of candidate gene knockdown experiments are pre-
sented in Fig. 5a–b and Additional file 3.
The putative interactions between DmManf and the
21 candidate genes were further analysed by ubiquitous
knockdown of the candidate genes (stage 4 in Additional
file 2, B-C in Additional file 3, Additional file 4). We
used tub-GAL4 driver and compared pupal and adult
viability between wild type background and with
DmManf overexpression to see whether overexpression
of DmManf would affect the phenotypes caused by
ubiquitous knockdown of the candidate genes. For ex-
ample, simultaneous overexpression of DmManf signifi-
cantly decreased the pupal viability for ubiquitous
knockdown of CSN3 (COP9 complex homolog subunit
3) encoding a protein involved in regulation of the ubi-
quitin conjugation pathway (B-C in Additional file 3).
Overexpression of DmManf alone with tub-GAL4 in
wild type background showed no obvious phenotype or
affected fly viability [13].
Gene ontology terms of potential DmManf interacting
partners
We analysed the Gene Ontology (GO) terms of the 21
candidate genes (Table 2). Four of the candidate genes
were unannotated and excluded from the analysis. Most
enriched GO terms were related to ubiquinone related
processes (2 genes), mitochondrial cellular compartment
(6 genes) and cellular metabolic process (13 genes).
Alterations in genes annotated with GO terms related to
metabolism were also observed in our previous micro-
array analysis [14]. The enrichment of mitochondrial
genes was notable: 29% of our candidate genes were
annotated with mitochondria as cellular compartment
while according to FlyBase [40], only 5% of all Drosoph-
ila genes have such annotation (http://gostat.wehi.
edu.au/). Furthermore, three of our candidate genes
(Ts, l(2)37Bb and CG9249) with unknown cellular com-
partment have human homologues which are anno-
tated to mitochondria.
DmManf partially localizes to mitochondria and
genetically interacts with the ubiquinone synthesis
pathway
To examine further the interaction between DmManf
and genes encoding mitochondrial proteins, we studied
the subcellular localization of DmManf. According to
our previous analyses, DmManf is localized to several
cell compartments [14]. To detect mitochondria, we
used sqh-EYFP-Mito transgenic fly line [41]. When the
CNS of 3rd instar sqh-EYFP-Mito larvae were immuno-
histochemically stained with DmManf antibody, a partial
co-localization with mitochondrial marker was detected
(Fig. 5c and Additional file 5).
Two of our candidate genes were involved in the ubi-
quinone biosynthesis pathway, COQ7 (coenzyme Q7
homologue) and CG9249 (homologue of coenzyme Q3,
COQ3) (Fig. 4 and Fig. 6). Ubiquinone is an electron
carrier involved in respiratory electron transport chain
localized to inner mitochondrial membrane (reviewed in
[42, 43]). The knockdown of COQ7 caused more severe
phenotype with overexpression of DmManf than in wild
type background when MS1096-GAL4, 69B-GAL4 or
ubiquitous tub-GAL4 drivers were used. More specific-
ally, the silencing of COQ7 with MS1096-GAL4 led to
very mildly bent-up wings in wild type background
(a1 and a3 in Fig. 5a). With simultaneous overexpres-
sion of DmManf this phenotype was stronger leading
to small, wrinkled wings in adult males (a4 in Fig.
5a). The knockdown of COQ7 with 69B-GAL4 led to
mildly uneven surface of the wing in wild type back-
ground but to a wrinkled wing phenotype when
Table 1 Penetrance of the wing phenotype in adult flies of
DmManf knockdown with MS1096-GAL4
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Fig. 3 Knockdown of DmManf increases the number of mitotic cells in the wing disc. a Number of phosphorylated Histone-3 (pHis3) positive cells
was significantly increased in GFP-expressing area of wing discs of third instar male larvae when DmManf was knocked down with MS1096-GAL4 in
heterozygous DmManfΔ96 mutant background. UAS-GFP.nls was used to detect GAL4 expressing area. n = 30. *, P < 0.05, Student’s t-test. b Three
representative images of dorsal wing disc area showing pHis3 positive cells (magenta) and MS1096-GAL4 expression with UAS-GFP.nls (green). Scale
bar 10 μm. c-d Proportion of S/G2/M positive cells (green) was increased in MS1096-GAL4 expressing wing discs of third instar male larvae in DmManf
knockdown in comparison to wild type. act-His2Av-RFP (magenta) was used to mark all nuclei. Representative images of UAS-S/G2/M-Green driven
with MS1096-GAL4 in wild type and together with UAS-DmManf-RNAi are shown (d). Boxed magnifications in upper right corners show the
37.9 μm × 37.9 μm area of dorsal wing disc compartment (dashed rectangles in red) used for analysis. Scale bar 10 μm. n = 11 for wt; n = 7 for
DmManf-RNAi. **, P < 0.01, Student’s t-test
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Fig. 4 Overview of candidate genes for interaction partners of DmManf based on RNAi screen. UAS-x-RNAi lines were crossed to MS1096-GAL4
and 69B-GAL4 driver lines in wild type, heterozygous DmManfΔ96 mutant and DmManf overexpression background. Observed phenotypes of knockdown
flies in heterozygous DmManfΔ96 mutant background (het vs. wt) and DmManf overexpression background (OE vs. wt) were compared to phenotype of
knockdown flies in wild type background. Yellow (stronger phenotype) and green (rescued phenotype) represent affected phenotypes. Light gray (no
phenotype), gray (phenotype not affected) and dark gray (lethal phenotype) represent cases where heterozygous DmManfΔ96 mutant background or
overexpression of DmManf did not affect the phenotype caused by knockdown of target gene. For a comparison, results from microarray analysis (MAA)
[14] are presented; red and blue indicate up- and downregulation of target genes, respectively. Mutant larvae stands for zygotic DmManfΔ96 mutant larvae,
OE larvae for 69B-GAL4 > UAS-DmManfL3 larvae, and mutant embryos for maternal and zygotic DmManfΔ96 mutant embryos. Cellular compartment: Ch,
chromosome; Cy, cytoplasm; Ec, extracellular; Me, membrane; Mi, mitochondrion; Nu, nucleus; nd, no data available; Sg, signalosome; Sp, spliceosome. Het,
heterozygous DmManf mutant; MAA, microarray analysis; OE, overexpression
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DmManf was overexpressed (c1-c4 in Fig. 5a). When
COQ7 was ubiquitously knocked down with tub-
GAL4 in wild type background, lethality occurred dur-
ing pupal stage and no adults emerged (B-C in Additional
file 3). However, simultaneous overexpression of DmManf
led to complete lethality at larval stage (B in Additional
file 3). Ubiquitous knockdown of COQ7 with tub-GAL4
increased DmManf mRNA level determined by qPCR
analysis (Fig. 6a).
Knockdown of COQ3/CG9249 with 69B-GAL4 and
tub-GAL4 led to lethality at pupal and larval stages, re-
spectively, and was not affected by either heterozygous
DmManfΔ96 mutant background or overexpression of
DmManf (Fig. 4 and Additional file 4). When COQ3/
CG9249 was knocked down with MS1096-GAL4 in wild
type background, a bent-up phenotype was observed in
the adult wing (b1 and b3 in Fig. 5a, a1 and a3 in Fig. 5b).
This phenotype was stronger leading to wrinkled wings
when either simultaneous overexpression of DmManf
(b1-b4 in Fig. 5a) or heterozygous DmManfΔ96 mutant
background (a1-a4 in Fig. 5b) was used. Ubiquitous
knockdown of COQ3/CG9249 with tub-GAL4 showed a
very slight increase in DmManf mRNA levels detected by
qPCR analysis (Fig. 6a).
In Drosophila, only six genes are annotated to be
involved in processes related to the ubiquinone syn-
thesis pathway (GO:0006744 term in FlyBase, http://
flybase.org; Fig. 6b). We decided to study interaction
between DmManf and the rest of the ubiquinone syn-
thesis pathway genes, COQ2/CG9613, COQ6/CG7277,
COQ9/CG30493, and COQ4/CG32174 (Fig. 6b–c).
Wing-specific knockdown of any of these genes with
MS1096-GAL4 showed no phenotype (Fig. 6c).
Knockdown with semi-ubiquitous 69B-GAL4 driver
showed either no phenotype (in the case of COQ6
and COQ4) or led to lethality at pupal stage (COQ9
and COQ2) and observed phenotype was not altered
by either heterozygous DmManfΔ96 mutant back-
ground or simultaneous overexpression of DmManf
(Fig. 6c). Simultaneous overexpression of DmManf did
not affect the observed phenotype by ubiquitous knock-
down of COQ6, COQ9 and COQ4 with tub-GAL4.
However, we observed significantly decreased pupal
viability when COQ2 was ubiquitously knocked down
by tub-GAL4 in DmManf-overexpressing background
compared to the wild type background (B in Additional
file 3; Additional file 4).
DmManf genetically interacts with Irbp, the Drosophila
homologue of Ku70
Three dimensional structure of C-terminal domain of
human MANF shows the highest similarity with the SAP
domain of Ku70, an inhibitor of Bax-induced cell death
[22, 23]. Microinjected MANF encoding cDNA or protein
has also been shown to protect cultured mouse superior
cervical ganglion neurons from drug induced apoptosis
[10, 22]. In our genetic screen, we identified Irbp (Inverted
repeat-binding protein), a homologue of mammalian
Ku70, as a potential interacting partner of DmManf (Fig. 4).
In adult male flies, knockdown of Irbp with MS1096-GAL4
driver in wild type background showed a wrinkled wing
phenotype (a3 in Fig. 7a). When UAS-Irbp-RNAi was
driven with MS1096-GAL4 in heterozygous DmManfΔ96
mutant background, male flies showed a bent-up wing
phenotype, clearly milder than in wild type back-
ground (a4 in Fig. 7a). In female flies, no alteration
between wild type and heterozygous DmManfΔ96 mu-
tant background was detected (a1-a2 in Fig. 7a).
We noted that Irbp knockdown with MS1096-GAL4
resulted in smaller wing discs of 3rd instar wandering
larvae in comparison to wild type (Fig. 7b). We quanti-
fied the width of the wing disc above the wing pouch
area (indicated by red dashed line in Fig. 7b) and found
that in the Irbp knockdown flies the width of the wing
disc was significantly decreased in comparison to wild
type (Fig. 7c). We also studied whether the heterozygous
DmManf mutant background would affect the width of
the wing disc in Irbp knockdown larvae with MS1096-
GAL4 and thus explain the altered wing phenotype of
Irbp knockdown flies in this background. However, there
was no difference in the width of the wing disc when
Irbp was knocked down in wild type and heterozygous
DmManf mutant backgrounds (Fig. 7c).
We observed lethality at pupal stage when Irbp was
ubiquitously knocked down with tub-GAL4 (B in
Additional file 3). Simultaneous overexpression of
DmManf partially rescued this lethality to adulthood
(B-C in Additional file 3) suggesting that DmManf and
Irbp may act in the same pathway and have, to certain
extent, redundant function.
To examine whether altered expression level of Irbp
and DmManf affect each other, we collected embryos
of DmManf knockdown as well as wandering 3rd in-
star larvae of Irbp knockdown and DmManf overex-
pression with semi-ubiquitous 69B-GAL driver and
quantified Irbp and DmManf mRNA levels by qPCR
analysis. In DmManf knockdown embryos, DmManf
mRNA expression level was significantly decreased in
comparison to the control (Fig. 7d). Interestingly, Irbp
mRNA expression was also significantly decreased in
DmManf knockdown embryos (Fig. 7d) indicating that
loss of DmManf downregulated Irbp expression.
In Irbp knockdown larvae Irbp mRNA level was
significantly decreased while DmManf mRNA expres-
sion was not altered (Fig. 7e). In DmManf-
overexpressing larvae, the level of Irbp mRNA did not
differ from the control genotype (Fig. 7e). When Irbp
knockdown was done in wild type and DmManf-
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overexpressing backgrounds, the decreased Irbp
mRNA level was not affected (Fig. 7e) indicating that
the overexpression of DmManf does not neither
induce nor repress Irbp mRNA expression. We also
studied the effect of Irbp knockdown on DmManf
protein expression by investigating wing discs of Irbp
knockdown 3rd instar larvae. In line with our qPCR
analysis, DmManf immunoreactivity was not altered
in Irbp knockdown with MS1096-GAL4 in compari-
son to wild type (Fig. 7b).
Based on the structural homology between the
Bax-inhibiting SAP domain of Ku70 and C-terminal
domain of MANF [22, 23], we hypothesized that the
total loss of DmManf in vivo could lead to decreased
inhibition of Bax followed by increased cell death and
subsequent DmManfΔ96 mutant lethality. Thus, we
tested whether the loss of Debcl (death executioner
Bcl-2 homologue), a homologue to mammalian proa-
poptotic Bax subfamily, could rescue the DmManfΔ96
mutant lethality in vivo. We used two debcl mutant
alleles (loss-of-function allele debclE26 and putative
dominant negative allele debclW105) to abolish en-
dogenous Debcl [44] and UAS-debcl-RNAi line to-
gether with ubiquitous da-GAL4 driver to knock
down Debcl. However, neither the loss nor silencing
of Debcl could rescue the DmManfΔ96 mutant lethal-
ity (Additional file 6) suggesting that during develop-
ment DmManf action through other molecular
systems than Debcl is more crucial for viability.
Discussion
MANF and CDNF form an evolutionarily conserved
family of neurotrophic factors [1–3]. Since their discov-
ery, increasing data suggests that these proteins possess
other characteristics beyond their neurotrophic proper-
ties. The loss of Drosophila homologue, DmManf, results
in lethality at early developmental stages with neuronal
and cuticular defects [3]. Thus, we wanted to explore
Table 2 Enrichment of Drosophila GO terms in the partial RNAi screen
GO ID GO term Genes Count Total P-Value
GO:0006743 ubiquinone metabolic process COQ7, COQ3/CG9249 2 2 0.013
GO:0006733 oxidoreduction coenzyme
metabolic process
COQ7, COQ3/CG9249 2 2 0.013
GO:0042375 quinone cofactor metabolic
process
COQ7, COQ3/CG9249 2 2 0.013
GO:0031966 mitochondrial membrane COQ7, ND75, Tom20, CG6455 4 34 0.033
GO:0005740 mitochondrial envelope COQ7, ND75, Tom20, CG6455 4 37 0.035
GO:0005739 mitochondrion COQ7, Hsp68, Aats-phe, ND75, Tom20,
CG6455
6 106 0.035
GO:0031975 envelope COQ7, ND75, Tom20, CG6455 4 47 0.058
GO:0031967 organelle envelope COQ7, ND75, Tom20, CG6455 4 47 0.058
GO:0044237 cellular metabolic process betaTry, COQ7, dome, Hsp68, Ku70/Irbp,
ND75, Aats-phe, pABp, Spn27A, Taf5, Ts,
Cdk12/CG7597, COQ3/CG9249
13 569 0.064
GO:0031090 organelle membrane COQ7, ND75, Tom20, CG6455 4 54 0.078
Analysis of Gene Ontology (GO) terms was performed on 21 candidate genes by GOstat (http://gostat.wehi.edu.au/). GO IDs with P-value <0.1, corresponding GO
terms and list of genes are presented. Count, number of our candidate genes mapping to a GO term; Total, number of genes in our primary screen annotated
with each GO term
(See figure on previous page.)
Fig. 5 Knockdown of candidate genes is affected by genetically altered DmManf level. Overexpression of DmManf (a) and heterozygous
DmManfΔ96 mutant background (b) affect phenotypes of candidate gene knockdown with wing driver MS1096-GAL4 (a and b in a, a in b) and
semi-ubiquitous driver 69B-GAL4 (c and d in a, b in b). The knockdown of COQ7 and CG9249 are discussed in the main text. Knockdown of
Spn27A (Serpin-27A, an inhibitor of serine-type endopeptidase activity) with 69B-GAL4 resulted in distal blister phenotype (arrow) with incomplete
penetrance (d1 and d3 in a). When DmManf was simultaneously overexpressed, the prevalence of blistered phenotype was significantly decreased (d2 and
d4 in a and data not shown). Knockdown of betaTry (betaTrypsin, a serine-type endopeptidase involved in proteolysis) with 69B-GAL4 caused a blistered
wing phenotype (arrow) with incomplete penetrance (b1 and b3 in b). The heterozygous DmManfΔ96 mutant background significantly suppressed the
prevalence of this blistered wing phenotype (b2 and b4 in b and data not shown). The percentages in d1-d4 in A and b1-b4 in B represent the proportion
of adult flies with indicated phenotype. Number of analysed adults in (a): d1, 75; d2, 127; d3, 63; d4, 142; and in (b): b1, 325; b2, 189; b3, 286; b4, 236. Scale
bar 1 mm. OE, overexpression. c Anti-DmManf (magenta) partially co-localized with mitochondrial marker sqh-EYFP-Mito (green) in the thoracic CNS of 3rd
instar larvae. Images consist of four laser confocal sections. Nuclei are shown in blue and gray represents the co-localization of anti-DmManf and sqh-EYFP-
Mito. See Additional file 5 for 3D volume rendering. Scale bar 3 μm
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Fig. 6 DmManf interacts with genes involved in the ubiquinone synthesis pathway. a Quantitative RT-PCR analysis showed increased DmManf
mRNA level when COQ7 was ubiquitously knocked down with tub-GAL4. UAS-lacZ was used as a wild type control. b A schematic presentation of ubi-
quinone synthesis pathway according to Kyoto Encyclopedia of Genes and Genomes (http://www.genome.jp/kegg/, pathway ID 00130). Genes marked
with yellow were found to genetically interact with DmManf. c UAS-RNAi lines of genes involved in ubiquinone synthesis pathway were crossed to
MS1096-GAL4 and 69B-GAL4 drivers in wild type, heterozygous DmManfΔ96 mutant or DmManf overexpression background. See Fig. 4 legend for interpret-
ation and Additional file 2 for schematic presentation of the crosses. Het, heterozygous DmManfΔ96 mutant; MAA, microarray analysis; ND, not determined;
OE, overexpression
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the tissue-specific effects of knockdown of DmManf
using UAS-RNAi approach. In a previous study, neither
neuronal nor glial knockdown of DmManf showed any
obvious phenotypic effects without the overexpression of
Dicer-2, a component of RNAi machinery [45]. Here, we
demonstrated that knockdown of DmManf by UAS-
DmManf-RNAi construct is effective and specific. The
ubiquitous knockdown resembled the lethal phenotype
of homozygous DmManfΔ96 mutants. We detected a
phenotype in the wing when knocking down DmManf
with a wing-specific driver MS1096-GAL4. The wing
phenotype was stronger in heterozygous DmManfΔ96
mutant background as compared to the wild type
background further demonstrating the specificity of
UAS-DmManf-RNAi construct. Although the phenotype
of small or even absent wings observed in the DmManf
knockdown adult males would suggest a decrease in cell
number, the number of mitotic cells was significantly
increased in the wing disc of DmManf knockdown
larvae. Our results are in accordance with the previous
study showing that the silencing of human MANF in
HeLa cells stimulated cell proliferation [17]. The in-
creased appearance of the mitotic markers used in this
study could also be due to prolonged M phase of cell
cycle. This would be in line with our finding that the
density of cells was not altered between wild type and
DmManf knockdown larval wing discs (data not shown).
Prolonged cell cycle would result in decreased growth
rate and could explain the wing phenotype observed in
DmManf knockdown flies. Furthermore, we failed to
detect any differences with apoptotic markers (data not
shown) indicating that the wing phenotype did not result
from increased cell death at the 3rd instar larval stage.
However, it is possible that apoptosis could take place
later at the pupal stage.
The knowledge on the molecular mechanisms and sig-
naling pathways of MANF/CDNF family proteins is still
limited. Previous studies show strong evidence support-
ing MANF function in ER stress and unfolded protein
response [8, 9, 15, 17, 20]. In our recent study, we
showed that the expression of DmManf mRNA is upreg-
ulated in response to ER stress-inducing drugs and that
DmManf genetically interacts with genes known to func-
tion in ER stress and unfolded protein response [13]. In
the current work we utilized the wing phenotype de-
tected in DmManf knockdown flies and performed a
partial unbiased screen of two genome-wide UAS-RNAi
libraries using the Drosophila in vivo model. The pri-
mary screen was done with wing-specific driver
(MS1096-GAL4) and the selection of candidate genes
was based solely on phenotypic similarity to DmManf-
knockdown flies. We were unable to find genes with ER-
and ER stress-related functions as potential interaction
partners for DmManf because of this criterion:
knockdown of ER stress related genes with MS1096-
GAL4 driver resulted in distinct phenotypes in compari-
son to the knockdown of DmManf [13]. In the secondary
and tertiary screens we knocked down the candidate genes
in (1) heterozygous DmManfΔ96 mutant background to
decrease the level of endogenous DmManf protein and (2)
with simultaneous overexpression of DmManf to increase
it [3]. Thus, we aimed to discover whether the phenotype
caused by silencing of a particular gene would be affected
by manipulating DmManf expression level.
Although our screen was only partial, it strongly sug-
gested that DmManf interacts with genes encoding
mitochondrial proteins. Mitochondria play crucial roles
e.g. in oxidative phosphorylation and Ca2+ signaling, and
their dysfunctional biogenesis and metabolism are
involved in a variety of human diseases (reviewed in
[46–48]). We found that DmManf partially co-localized
with the mitochondrial marker sqh-EYFP-Mito. Deeper
analysis revealed that strongest DmManf expression was
detected adjoining the mitochondrial marker. In sqh-
EYFP-Mito marker, the fluorophore is directed to
mitochondria by the signal peptide of human Cox8A
(cytochrome C oxidase subunit 8A) and localized to the
mitochondrial matrix [41]. Since DmManf is also local-
ized to ER [10, 14], the observed co-localization could
be on the membranes connecting ER and mitochondria.
DmManf could take part in the ER-mitochondrial cross-
talk and disturbances in DmManf protein levels could
affect protein transport to mitochondria. A specific
complex, TOM (translocase of outer membrane), is
needed for proper targeting of mitochondrial proteins
encoded by nuclear DNA (reviewed in [49]). We identi-
fied genetic interaction between DmManf and Tom20
(Translocase of the outer membrane 20, homologue to
human TOMM20 and TOMM20-L), a receptor subunit
of TOM. Interestingly, another receptor protein of
TOM, Maggie/TOMM22 has been shown to mediate
localization of pro-apoptotic Debcl (homologue of
mammalian Bax) to mitochondria in Drosophila [50].
Bax, together with other members of the Bcl-2 protein
family, regulates permeabilization of mitochondrial outer
membrane during apoptosis (reviewed in [51]). Previous
studies have revealed a role for MANF in Bax-induced
cell death in vitro [10, 22]. In addition, our screen data
suggests a genetic interaction between MANF and
Ku70/Irbp, an inhibitor of Bax/Debcl. In future, it would
be interesting to evaluate whether DmManf co-localizes
with TOM proteins and whether Irbp or Debcl have any
role in this interaction.
Two genes from the ubiquinone synthesis pathway,
COQ7 and CG9249/COQ3, were included in our
primary screen and identified as candidate interacting
partners of DmManf. We also found evidence for inter-
action between DmManf and a third component of
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ubiquinone synthesis pathway, CG9613/COQ2. The
knockdown of COQ7 or CG9249/COQ3 resulted in
elevated DmManf mRNA levels. The best known func-
tion of ubiquinone, also known as coenzyme Q (Q), is
its participation in electron transport chain (ETC) by
transferring electrons from complexes I and II to
complex III (reviewed in [42, 43, 52]). COQ7 hydroxyl-
ates demethoxyubiquinone (DMQ) into hydroxyquinone
[53] from which ubiquinone is formed by COQ3 [54].
Loss of COQ7 (also known as Mclk-1 in mice, clk-1 in
nematodes) leads to Q deficiency and impaired ATP syn-
thesis [55–58]. Q deficiency in humans (OMIM 607426)
is associated with variety of clinical manifestations,
mostly neuronal and muscular defects (reviewed e.g. in
[59]). Importantly, increasing evidence suggests that
mitochondrial dysfunction is one of the main causes of
PD (reviewed e.g. in [48]) and studies on neuroprotec-
tion by Q treatment in PD models have been promising
(reviewed in [60]). Q deficiency has been linked to
destabilization of mitochondrial complex I [61]. Com-
plex I is also associated with PD as mutations in its sub-
units are found to be involved in a familial form of PD
(OMIM 556500; reviewed in [48]). Furthermore, toxins
used to induce PD-like symptoms in animal models in-
clude MPTP, rotenone and paraquat which all interfere
with complex I functionality [62, 63]. In addition to
genes involved in Q synthesis, we found homologues for
two genes linked to human mitochondrial complex I defi-
ciency (OMIM 252010), ND75 (NDUFS1) and l(2)37Bb
(FOXRED1) to genetically interact with DmManf. Consid-
ering all our data indicating a mitochondrial function,
DmManf could affect the oxidative phosphorylation,
directly or indirectly. In future studies, the connection be-
tween DmManf protein and its function in mitochondria
should be thoroughly examined.
Alternatively, DmManf could play a role in maintain-
ing cellular Ca2+ homeostasis, an important function of
both mitochondria and ER, based on Ca2+-dependent
binding of mammalian MANF and GRP78 [8]. In our
previous study, cultured Schneider 2 -cells showed a
strong induction of DmManf mRNA expression in
response to thapsigargin, an inhibitor of ER membrane-
resident Ca2+ ATPase, which depletes Ca2+ from ER
[13]. Additionally, one of our candidate genes, CG6455,
is homologous to human IMMT (inner membrane
protein, mitochondrial) predicted with a function in
mitochondrial Ca2+ homeostasis.
For several of our candidate genes, e.g. CG9249/COQ3,
knockdown with MS1096-GAL4 in both DmManfΔ96 het-
erozygous mutant (with decreased DmManf protein level)
and overexpression (with increased DmManf protein
level) background resulted in more severe phenotype in
comparison to the phenotype observed in wild type back-
ground. This suggests that knockdown of certain genes
together with the imbalance of DmManf protein level af-
fects overall cellular homeostasis rather than disturbs a
putative stoichiometric relationship between DmManf
and candidate gene encoded protein levels. Furthermore,
while the genetic interaction discovered may represent a
physical or biochemical interaction, it might also indicate
a secondary effect resulting from involvement of DmManf
and candidate gene in the same signaling pathway or bio-
logical process.
Conclusions
This study revealed that DmManf is involved in Dros-
ophila wing development and expanded our knowledge
on the role of MANF in the maintenance of cellular
homeostasis. Importantly, we discovered novel genetic
interacting partners of DmManf and our study suggests
that MANF has a role in mitochondrial function. These
data help us understand the molecular mechanism of
the evolutionarily conserved MANF/CDNF protein
family in future studies.
Methods
Fly strains and antibodies
Fly stocks and crosses were maintained at 25 °C. The
following fly lines were used in the study: w−, UAS-
DmManf133 (line L3), UAS-DmManf135 (line L5) and
DmManfΔ96/TM6 Tb Sb EYFP [3], UAS-HsMANFL2 and
UAS-HsCDNFL1 [10], UAS-lacZ [31]. The following
lines were obtained from Bloomington Drosophila Stock
Center: 69B-GAL4 (#1774, [31]), A9-GAL4 (#8761,
[38]), da-GAL4 (#5460, [64]), en2.4-GAL4e16E (#30564,
A. Brand & K. Yoffe, unpublished), MS1096-GAL4
(See figure on previous page.)
Fig. 7 The Drosophila homologue of Ku70, Irbp, is a genetic interacting partner of DmManf. a Heterozygous DmManfΔ96 mutant background
affected phenotype of Irbp knockdown with wing driver MS1096-GAL4 in adult male flies (a3-a4). Scale bar 1 mm. b-c The wing discs of Irbp knockdown
with MS1096-GAL4 showed significantly decreased width (red dashed line) in comparison to control genotype (MS1096-GAL4; UAS-mCD8-GFP). n = 8
(control), n = 5 (Irbp-RNAi in wild type background), n = 7 (Irbp-RNAi in heterozygous DmManfΔ96 mutant background). **, P < 0.01, ***, P < 0.001, Student’s
t-test. n.s., not significant. Scale bar 50 μm. d-e Knockdown embryos of DmManf with 69B-GAL4 showed decreased DmManf and Irbp mRNA levels (d) and
Irbp mRNA expression was decreased in 3rd instar larvae of Irbp knockdown with 69B-GAL4 analysed by qPCR (e). Overexpression of DmManf did not affect
Irbp mRNA expression. DmManf mRNA expression was not altered in Irbp knockdown with 69B-GAL4. Overexpression of DmManf with 69B-GAL4 increased
DmManf mRNA level (relative mRNA expression >30; not shown). *, P < 0.05, **, P < 0.01, ***, P < 0.001, Student’s t-test
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(#8860, [37]), salm-GAL4 (#5818, [65]), Ser-GAL4
(#6791, [66]), tub-GAL4/TM6 Tb Sb EYFP (#5138) and
UAS-mCD8-GFP (#5130) [67], debclE26 (#27342) and
debclW105/CyO (#27341) [44], act-His2Av-mRFP
(#23651, [68]), UAS-GFP.nls (#4775, [31]) and sqh-
EYFP-Mito (#7194, [41]). UAS-S/G2/M-Green was
obtained from Kyoto Stock Center (#109676, [36]).
Combination of act-His2Av-mRFP and UAS-S/G2/M-
Green in 2nd chromosome was a kind gift from Jinghua
Gui. T(2;3)SM6a-TM6B Tb translocation balancer was
used in viability studies (referred as SM6-TM6). UAS-
RNAi lines were obtained from Vienna Drosophila RNAi
Center and National Institute of Genetics (Additional
file 7). Adult flies were imaged with ProgRes SpeedXT
camera (Jenoptik). The following antibodies were used:
rabbit anti-DmManf [3], rabbit anti-phospho-Histone
H3 (Ser10) (06–570, Upstate), anti-α-tubulin (DM1A,
Sigma).
Immunohistochemistry, confocal microscopy and image
analysis
Third instar larval wing discs and CNS were dissected in
PBS and fixed with 4% paraformaldehyde in PBS or
PEM (100 mM PIPES pH 7.0, 2 mM EGTA, 1 mM
MgSO4) for 30 min. Fixed tissues were washed with PBT
(0.1% Triton X-100 in PBS) and blocked with blocking
solution (1% BSA in PBT) for 1 h. Tissues were incu-
bated with primary antibody overnight at 4 °C and with
secondary antibody for 1 h in room temperature, and
mounted in VECTASHIELD® Mounting Medium
(Vector Laboratories). Samples were imaged with TCS
SP5 laser scanning microscope (Leica Microsystems)
equipped with HCX PL APO 20×/0.7 mm Imm Corr
glycerol immersion objective or HC PL APO 10×/0.4 air
objective. For co-localization study, Zeiss LSM5 DUO
confocal microscope equipped with PL APO 100×/1.4
oil objective was used. ImageJ 1.43u [69], Imaris 7.6.0
and Imaris 8.4.1 (Bitplane Inc.) were used for image
analysis. For quantification of pHis3 positive cells, auto-
matic “Spots” algorithm in Imaris 7.6.0 was used. For
quantification of S/G2/M-Green and act-His2Av-RFP
positive cells, a 37.9 μm × 37.9 μm area of the dorsal
wing pouch was analyzed with the Spots algorithm in
Imaris 8.4.1.
Western blot analysis
Lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl,
1% Triton X-100, 1 mM EDTA) supplemented with
Complete proteinase inhibitor tablets (Roche) was used
in homogenization of larvae. Western blotting was done
according to manufacturer’s instructions and visualized
by the Odyssey infrared imager (Li-Cor).
Adult wing preparations
Adult flies were dipped into 70% ethanol and fixed
10 min in clove oil (Sigma). Wings were dissected and
mounted in 70% Canada Balsam/30% xylene. Nikon
SMZ1500 was used for imaging.
Quantitative RT-PCR
Larvae were grown at 25 °C on apple juice plates and
collected 50–54 h after egg laying. For 3rd instar larval
samples wandering larvae were collected from the vials.
Embryos were collected from apple juice plates 16–22 h
after egg laying. NucleoSpin® RNA II (Macherey-Nagel)
was used in extraction and purification of total RNA.
DNase treatment was done on-column according to the
manufacturer’s instructions. First strand cDNA was
synthesized from total RNA (1 μg) using RevertAid
Premium Reverse Transcriptase (Thermo Scientific) and
Oligo(dT18) primer at 53 °C according to manufacturer’s
instructions. Expression of DmManf mRNA was quanti-
fied by LightCycler® 480 Real-Time PCR System with
Lightcycler 480 SYBR Green I master mix (Roche) with
primers DmManf forward 5′-AATCTGCGACCTTCG
CTATG-3’and DmManf reverse 5′-TCGTTGAGGAT
TTTCTTCAGG-3′ [14]. Irbp was amplified with
primers Irbp forward 5′-AGTTCATCACGTTGTCAA
GAGC-3′ and Irbp reverse 5′-TACGATCGGACAGG
ATTTCG-3′ [70]. RpL32 was amplified as a reference
gene with primers RpL32 forward 5′-CGGATCGATA
TGCTAAGCTGT-3′ and RpL32 reverse 5′-GCGC
TTGTTCGATCCGTA-3′ [14]. PCR efficiency (E) of
each primer pair was determined from a relative stand-
ard curve. For DmManf, E = 1.98; for Irbp, E = 2.00; for
RpL32, E = 1.97. Equation E-Cp in which Cp indicates
a crossing point was used to calculate relative con-
centration of DmManf, Irbp and RpL32 mRNA in
each sample. To present the results, the concentra-
tion of DmManf and Irbp was normalized to the
level of RpL32. Each sample was analysed as a
duplicate.
Statistical analysis
Means were compared by Student’s t-test, null hypothesis
was rejected at P < 0.05. Statistical analyses were per-
formed by using Microsoft® Excel Analysis ToolPak
(Microsoft® Office Professional Plus 2010). For pupal
viability studies, normal (Tubby+; Tb+) and squat (Tb−)
pupae were counted, the number of Tb+ pupae was
divided by the number of all pupae and normalized to ex-
perimentally determined ratio from tub-GAL4/TM6 Tb
Sb cross to wild type and to wild type balanced against
SM6-TM6 translocation balancer (Additional file 4 and
Additional file 8, wild type and DmManf overexpression
data previously reported in [13]). For preliminary analyses
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two vials were counted and statistical analysis was done
based on six vials with minimum of 40 pupae. For
genotypes showing incomplete penetrance of the wing
phenotypes, quantification of the penetrance was
performed by counting adult flies with and without
phenotype from 4 vials per genotype.
Gene ontology analysis
Gene Ontology (GO) analysis was performed for genes
considered as hits from our UAS-RNAi screen (21
genes) against the set of genes included in the primary
screen (approximately 2800 randomly selected genes).
GOstat (http://gostat.wehi.edu.au/) was used with
default tool settings. A complete list of overrepresented
(p < 0.1) GO terms is presented in Table 2.
Additional files
Additional file 1: Two DmManf-RNAi constructs in three independent
transformant lines are available in VDRC. A tiff file. A) Alignment of DmManf-
RNAi constructs 4793 and 108792. Construct 4793 targets last three exons of
the DmManf gene with no predicted off-targets (VDRC data sheet).
Construct 108792 targets exon 4 and 3′ UTR and has one predicted off-
target (Sulfated/CG6725; VDRC data sheet). Construct 4793 in transformant
line 12835 was used in further studies. B) Different UAS-DmManf-RNAi
transformant lines show similar phenotypes when driven with wing-specific
MS1096-GAL4. For all lines, heterozygous DmManfΔ96 mutant background
lead to stronger wing phenotype and overexpression (OE) of DmManf
rescued the wing phenotype. C) Alignment of UAS-DmManf-RNAi construct
(ID 4793) with UAS-HsMANF and UAS-HsCDNF constructs. Strongest alignment
is shown in green (HsMANF) and purple (HsCDNF). VDRC, Vienna Drosophila
RNAi Center; Tf, transformant line; OE, overexpression. (TIFF 2536 kb)
Additional file 2: Screen for genetic interaction partners of DmManf. A
tiff file. A) Scheme of the crosses used in the partial RNAi library screen.
First, randomly selected UAS-x-RNAi lines were crossed to wing-specific
driver line MS1096-GAL4 (1). Lines showing similar phenotype to
UAS-DmManf-RNAi lines were selected to the next stage. Second, two
GAL4 drivers, wing-specific MS1096-GAL4 and semi-ubiquitous 69B-GAL4,
were used in both wild type and heterozygous DmManfΔ96 mutant background
(2) – UAS-x-RNAi lines showing distinct phenotypes in wild type and
heterozygous DmManfΔ96 mutant backgrounds were selected. Secondary
stage was repeated for selected UAS-x-RNAi lines in order to ensure the
observed interactions. At stage 3, 69B-GAL4 and MS1096-GAL4 drivers were
used to express UAS-x-RNAi lines with or without UAS-DmManf
overexpression construct (3). Based on stages 2 and 3, 21 UAS-x-RNAi lines
were selected as candidates for final stage 4. (4) UAS-x-RNAi lines were
expressed with tub-GAL4 with and without DmManf overexpression to
study whether high levels of DmManf affected ubiquitous silencing of
selected genes (see Additional file 4). B-C) DmManf (magenta) was
ubiquitously expressed in the wing disc of 3rd instar larvae. MS1096-GAL4
expression detected by UAS-mCD8-GFP (green) was found mainly in the
dorsal wing compartment but also in other regions of the wing disc (B).
MS1096-GAL4 expression pattern was also detected in the CNS (C). Nuclear
counterstain DAPI (gray) was used to mark the tissue morphology. Scale bar
50 μm. D) Insertion of GAL4 construct GawB in driver lines 69B-GAL4 and
MS1096-GAL4 [31] did not affect adult fly phenotype (+/+, top row).
Heterozygous DmManf mutation (DmManfΔ96/+, middle row) or
overexpression of DmManf (UAS-DmManfL5, bottom row) together with
69B-GAL4 and MS1096-GAL4 insertions showed no obvious phenotype
in adult flies. (TIFF 3486 kb)
Additional file 3: Examples of candidate genes for interacting partners
of DmManf. A tiff file. A) MS1096-GAL4 was used to silence candidate
genes in wild type, heterozygous DmManfΔ96 mutant (DmManfΔ96/+) and
DmManf overexpression (+ DmManf OE) backgrounds. With many candidate
genes, both heterozygous DmManfΔ96 mutant background and DmManf
overexpression resulted in more severe phenotype. For example, knockdown
of Tom20 (Translocase of outer membrane 20, a mitochondrial transmem-
brane transporter protein) showed a mildly wrinkled wing phenotype in wild
type background (a1). When heterozygous DmManfΔ96 mutant background
(a2) or simultaneous DmManf overexpression was used (a3), wings were
strongly wrinkled. Similarly, knockdown of Cdk12 (a cyclin-dependent protein
serine/threonine kinase; b1-b3) showed stronger phenotype both in heterozy-
gous DmManfΔ96 mutant and DmManf-overexpressing backgrounds.
Complete list of the alterations is presented in Fig. 4. B) Quantitative
analysis of ubiquitous knockdown of candidate genes CSN3, Irbp, COQ7
and ubiquinone synthesis related gene COQ2 showed altered pupal via-
bility with DmManf overexpression (+ DmManf OE, red) in comparison
to wild type background (− DmManf OE, blue). tub-GAL4/+ flies were
used as wild type control. C) Proportion of emerged adults when candi-
date genes were ubiquitously knocked down with tub-GAL4 with (+
OE) or without (− OE) DmManf overexpression. *, P < 0.05; ***,
P < 0.001, Student’s t-test. Amount of pupae and adults analysed in
B-C are presented in Additional file 4. Proportion of Tb+ pupae was
normalized to experimentally determined proportion of Tb+ pupae
(see Additional file 8, wild type and wild type/SM6-TM6). (TIFF 1442 kb)
Additional file 4: Results from ubiquitous knockdown studies of
UAS-RNAi lines with and without DmManf overexpression. A pdf file. (PDF 10 kb)
Additional file 5: Video of 3D volume rendering of co-localization of a-
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